Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Correction for Giuntini et al., "Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection".

Giuntini S, Stoppato M, Sedic M, Ejemel M, Pondish JR, Wisheart D, Schiller ZA, Thomas WD Jr, Barry EM, Cavacini LA, Klempner MS, Wang Y.

Infect Immun. 2018 Nov 20;86(12). pii: e00713-18. doi: 10.1128/IAI.00713-18. Print 2018 Dec. No abstract available.

2.

Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection.

Giuntini S, Stoppato M, Sedic M, Ejemel M, Pondish JR, Wisheart D, Schiller ZA, Thomas WD Jr, Barry EM, Cavacini LA, Klempner MS, Wang Y.

Infect Immun. 2018 Jul 23;86(8). pii: e00355-18. doi: 10.1128/IAI.00355-18. Print 2018 Aug. Erratum in: Infect Immun. 2018 Nov 20;86(12):.

3.

Structure-Based Design of Hepatitis C Virus Vaccines That Elicit Neutralizing Antibody Responses to a Conserved Epitope.

Pierce BG, Boucher EN, Piepenbrink KH, Ejemel M, Rapp CA, Thomas WD Jr, Sundberg EJ, Weng Z, Wang Y.

J Virol. 2017 Sep 27;91(20). pii: e01032-17. doi: 10.1128/JVI.01032-17. Print 2017 Oct 15.

4.

Structural and molecular analysis of a protective epitope of Lyme disease antigen OspA and antibody interactions.

Shandilya S, Kurt Yilmaz N, Sadowski A, Monir E, Schiller ZA, Thomas WD Jr, Klempner MS, Schiffer CA, Wang Y.

J Mol Recognit. 2017 May;30(5). doi: 10.1002/jmr.2595. Epub 2016 Nov 16.

5.

Pre-exposure Prophylaxis With OspA-Specific Human Monoclonal Antibodies Protects Mice Against Tick Transmission of Lyme Disease Spirochetes.

Wang Y, Kern A, Boatright NK, Schiller ZA, Sadowski A, Ejemel M, Souders CA, Reimann KA, Hu L, Thomas WD Jr, Klempner MS.

J Infect Dis. 2016 Jul 15;214(2):205-11. doi: 10.1093/infdis/jiw151. Epub 2016 Apr 18.

6.

Management of knee osteoarthritis by combined stromal vascular fraction cell therapy, platelet-rich plasma, and musculoskeletal exercises: a case series.

Gibbs N, Diamond R, Sekyere EO, Thomas WD.

J Pain Res. 2015 Nov 9;8:799-806. doi: 10.2147/JPR.S92090. eCollection 2015.

7.

Resolving self-association of a therapeutic antibody by formulation optimization and molecular approaches.

Casaz P, Boucher E, Wollacott R, Pierce BG, Rivera R, Sedic M, Ozturk S, Thomas WD Jr, Wang Y.

MAbs. 2014;6(6):1533-9. doi: 10.4161/19420862.2014.975658.

8.

Migraine and tension-type headache treated with stromal vascular fraction: a case series.

Bright R, Bright M, Bright P, Hayne S, Thomas WD.

J Med Case Rep. 2014 Jun 30;8:237. doi: 10.1186/1752-1947-8-237.

9.

Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display.

Larimer BM, Thomas WD, Smith GP, Deutscher SL.

Mol Imaging Biol. 2014 Aug;16(4):449-58. doi: 10.1007/s11307-014-0724-5.

PMID:
24550054
10.

Analytical characterization of a monoclonal antibody therapeutic reveals a three-light chain species that is efficiently removed using hydrophobic interaction chromatography.

Wollacott RB, Casaz PL, Morin TJ, Zhu HL, Anderson RS, Babcock GJ, Que J, Thomas WD Jr, Ozturk SS.

MAbs. 2013 Nov-Dec;5(6):925-35. doi: 10.4161/mabs.26192. Epub 2013 Aug 19.

11.

Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation.

Calao M, Sekyere EO, Cui HJ, Cheung BB, Thomas WD, Keating J, Chen JB, Raif A, Jankowski K, Davies NP, Bekkum MV, Chen B, Tan O, Ellis T, Norris MD, Haber M, Kim ES, Shohet JM, Trahair TN, Liu T, Wainwright BJ, Ding HF, Marshall GM.

Oncogene. 2013 Aug 1;32(31):3616-26. doi: 10.1038/onc.2012.368. Epub 2012 Aug 20.

PMID:
22907436
12.

The case for trypsin release of affinity-selected phages.

Thomas WD, Smith GP.

Biotechniques. 2010 Sep;49(3):651-4. doi: 10.2144/000113489.

13.

Corruption of phage display libraries by target-unrelated clones: diagnosis and countermeasures.

Thomas WD, Golomb M, Smith GP.

Anal Biochem. 2010 Dec 15;407(2):237-40. doi: 10.1016/j.ab.2010.07.037. Epub 2010 Aug 6.

14.

Treatment with monoclonal antibodies against Clostridium difficile toxins.

Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, Gerding DN, Nichol G, Thomas WD Jr, Leney M, Sloan S, Hay CA, Ambrosino DM.

N Engl J Med. 2010 Jan 21;362(3):197-205. doi: 10.1056/NEJMoa0907635.

15.

Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus.

Broering TJ, Garrity KA, Boatright NK, Sloan SE, Sandor F, Thomas WD Jr, Szabo G, Finberg RW, Ambrosino DM, Babcock GJ.

J Virol. 2009 Dec;83(23):12473-82. doi: 10.1128/JVI.01138-09. Epub 2009 Sep 16.

16.

Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression.

Thomas WD, Chen J, Gao YR, Cheung B, Koach J, Sekyere E, Norris MD, Haber M, Ellis T, Wainwright B, Marshall GM.

Oncogene. 2009 Apr 2;28(13):1605-15. doi: 10.1038/onc.2009.3. Epub 2009 Feb 23.

PMID:
19234491
17.

Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates.

Sloan SE, Hanlon C, Weldon W, Niezgoda M, Blanton J, Self J, Rowley KJ, Mandell RB, Babcock GJ, Thomas WD Jr, Rupprecht CE, Ambrosino DM.

Vaccine. 2007 Apr 12;25(15):2800-10. Epub 2006 Dec 29.

PMID:
17240489
18.

Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.

Babcock GJ, Broering TJ, Hernandez HJ, Mandell RB, Donahue K, Boatright N, Stack AM, Lowy I, Graziano R, Molrine D, Ambrosino DM, Thomas WD Jr.

Infect Immun. 2006 Nov;74(11):6339-47. Epub 2006 Sep 11.

19.

The estrogen-responsive B box protein is a novel regulator of the retinoid signal.

Cheung BB, Bell J, Raif A, Bohlken A, Yan J, Roediger B, Poljak A, Smith S, Lee M, Thomas WD, Kavallaris M, Norris M, Haber M, Liu HL, Zajchowski D, Marshall GM.

J Biol Chem. 2006 Jun 30;281(26):18246-56. Epub 2006 Apr 24.

20.

Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters.

Roberts A, Thomas WD, Guarner J, Lamirande EW, Babcock GJ, Greenough TC, Vogel L, Hayes N, Sullivan JL, Zaki S, Subbarao K, Ambrosino DM.

J Infect Dis. 2006 Mar 1;193(5):685-92. Epub 2006 Jan 27.

PMID:
16453264
21.

Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice.

Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD Jr, Coccia JA, Graziano RF, Srinivasan M, Lowy I, Finberg RW, Subbarao K, Vogel L, Somasundaran M, Luzuriaga K, Sullivan JL, Ambrosino DM.

J Infect Dis. 2005 Feb 15;191(4):507-14. Epub 2005 Jan 14.

PMID:
15655773
22.

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.

Jeffers SA, Tusell SM, Gillim-Ross L, Hemmila EM, Achenbach JE, Babcock GJ, Thomas WD Jr, Thackray LB, Young MD, Mason RJ, Ambrosino DM, Wentworth DE, Demartini JC, Holmes KV.

Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15748-53. Epub 2004 Oct 20.

23.

Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification.

Hansford LM, Thomas WD, Keating JM, Burkhart CA, Peaston AE, Norris MD, Haber M, Armati PJ, Weiss WA, Marshall GM.

Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12664-9. Epub 2004 Aug 16.

24.
25.

N-myc transcription molecule and oncoprotein.

Thomas WD, Raif A, Hansford L, Marshall G.

Int J Biochem Cell Biol. 2004 May;36(5):771-5. Review.

PMID:
15061133
26.

Surface plasmon resonance imaging studies of protein-carbohydrate interactions.

Smith EA, Thomas WD, Kiessling LL, Corn RM.

J Am Chem Soc. 2003 May 21;125(20):6140-8.

PMID:
12785845
27.

Parallel synthesis of glycomimetic libraries: targeting a C-type lectin.

Schuster MC, Mann DA, Buchholz TJ, Johnson KM, Thomas WD, Kiessling LL.

Org Lett. 2003 May 1;5(9):1407-10.

PMID:
12713285
28.

The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells.

Franco AV, Zhang XD, Van Berkel E, Sanders JE, Zhang XY, Thomas WD, Nguyen T, Hersey P.

J Immunol. 2001 May 1;166(9):5337-45.

30.

Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types.

Zhang XD, Nguyen T, Thomas WD, Sanders JE, Hersey P.

FEBS Lett. 2000 Oct 6;482(3):193-9.

31.
32.

Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters.

Giannasca PJ, Zhang ZX, Lei WD, Boden JA, Giel MA, Monath TP, Thomas WD Jr.

Infect Immun. 1999 Feb;67(2):527-38.

34.

CD4 T cells kill melanoma cells by mechanisms that are independent of Fas (CD95).

Thomas WD, Hersey P.

Int J Cancer. 1998 Jan 30;75(3):384-90.

35.

Expression of the co-stimulatory molecule CD40 on melanoma cells.

Thomas WD, Smith MJ, Si Z, Hersey P.

Int J Cancer. 1996 Dec 11;68(6):795-801.

36.

Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.

Lee CK, Weltzin R, Thomas WD Jr, Kleanthous H, Ermak TH, Soman G, Hill JE, Ackerman SK, Monath TP.

J Infect Dis. 1995 Jul;172(1):161-72.

PMID:
7797906
37.

Urease-specific monoclonal antibodies prevent Helicobacter felis infection in mice.

Blanchard TG, Czinn SJ, Maurer R, Thomas WD, Soman G, Nedrud JG.

Infect Immun. 1995 Apr;63(4):1394-9.

38.

Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis.

Pappo J, Thomas WD Jr, Kabok Z, Taylor NS, Murphy JC, Fox JG.

Infect Immun. 1995 Apr;63(4):1246-52.

39.

Evaluation of Fosthiazate for Management of Meloidogyne javanica in Florida Flue-cured Tobacco.

Rich JR, Dunn RA, Thomas WD, Breman JW, Tervola RS.

J Nematol. 1994 Dec;26(4 Suppl):701-4.

40.

Expression of the co-stimulatory molecule B7 on melanoma cells.

Hersey P, Si Z, Smith MJ, Thomas WD.

Int J Cancer. 1994 Aug 15;58(4):527-32.

PMID:
7520026
41.
42.
43.

Effects of trichloroethylene on hepatic and splenic lymphocytotoxic activities in rodents.

Wright PF, Thomas WD, Stacey NH.

Toxicology. 1991;70(2):231-42.

PMID:
1763417
44.

Effects of chlordimeform and its metabolite 4-chloro-o-toluidine on rat splenic T, B and tumoricidal effector cells.

Thomas WD, Craig GK, Stacey NH.

Immunopharmacology. 1990 Mar-Apr;19(2):79-86.

PMID:
2351536
45.

Expression of natural killer (NK) cell-specific alloantigens on a mouse NK-like cell line.

Smart YC, Stevenson KL, Thorne RF, Thomas WD, Hsu LH, Burton RC.

Immunol Cell Biol. 1989 Aug;67 ( Pt 4):239-42.

PMID:
2767713
47.
48.

The role of feticide in the management of severe twin transfusion syndrome.

Wittmann BK, Farquharson DF, Thomas WD, Baldwin VJ, Wadsworth LD.

Am J Obstet Gynecol. 1986 Nov;155(5):1023-6.

PMID:
3535514
49.

The 1981 presidential valediction.

Thomas WD.

Can Med Assoc J. 1981 Oct 15;125(8):904, 907-8, 913-4. No abstract available.

50.

Dr. W.D.S. Thomas: the past president looks back. Interview by David Woods.

Thomas WD.

Can Med Assoc J. 1981 Oct 15;125(8):898-903. No abstract available.

Supplemental Content

Loading ...
Support Center